Axonics Inc (NASDAQ: AXNX) is 14.06% higher on its value in year-to-date trading and has touched a low of $53.99 and a high of $70.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AXNX stock was last observed hovering at around $70.45 in the last trading session, with the day’s gains setting it 0.53%.
Currently trading at $70.98, the stock is 0.86% and 1.65% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.2 million and changing 0.75% at the moment leaves the stock 3.84% off its SMA200. AXNX registered 25.27% gain for a year compared to 6-month gain of 4.89%. The firm has a 50-day simple moving average (SMA 50) of $69.7832 and a 200-day simple moving average (SMA200) of $68.3423.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.05% loss in the last 1 month and extending the period to 3 months gives it a 3.12%, and is 0.75% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.35% over the week and 0.29% over the month.
Axonics Inc (AXNX) has around 797 employees, a market worth around $3.63B and $431.90M in sales. Fwd P/E is 82.18. Profit margin for the company is -1.31%. Distance from 52-week low is 31.46% and 0.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.82%).
The EPS is expected to grow by 281.25% this year
305.0 institutions hold shares in Axonics Inc (AXNX), with institutional investors hold 87.42% of the company’s shares. The shares outstanding are 50.77M, and float is at 50.30M with Short Float at 6.58%. Institutions hold 86.32% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 5.04 million shares valued at $338.93 million. The investor’s holdings represent 9.8988 of the AXNX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 4.34 million shares valued at $291.88 million to account for 8.5248 of the shares outstanding. The other top investors are ALPINE ASSOCIATES MANAGEMENT INC. which holds 2.11 million shares representing 4.1409 and valued at over $141.78 million, while FIL LTD holds 4.0071 of the shares totaling 2.04 million with a market value of $137.2 million.
Axonics Inc (AXNX) Insider Activity
The most recent transaction is an insider sale by Keese Kari Leigh, the company’s Chief Financial Officer. SEC filings show that Keese Kari Leigh sold 2,961 shares of the company’s common stock on Oct 02 ’24 at a price of $69.41 per share for a total of $0.21 million. Following the sale, the insider now owns 40362.0 shares.
Axonics Inc disclosed in a document filed with the SEC on Jan 31 ’24 that Noblett Karen (Chief Medical Officer) sold a total of 11,288 shares of the company’s common stock. The trade occurred on Jan 31 ’24 and was made at $67.74 per share for $0.76 million. Following the transaction, the insider now directly holds 34428.0 shares of the AXNX stock.
Still, SEC filings show that on Jan 31 ’24, Woock John (EVP, Chief Mktg/Strtgy Officer) disposed off 15,899 shares at an average price of $67.74 for $1.08 million. The insider now directly holds 77,403 shares of Axonics Inc (AXNX).
